Perrigo EBITDA 2010-2024 | PRGO
Perrigo Annual EBITDA (Millions of US $) |
|
---|---|
2023 | $514 |
2022 | $417 |
2021 | $719 |
2020 | $648 |
2019 | $567 |
2018 | $652 |
2017 | $1,021 |
2016 | $-1,567 |
2015 | $240 |
2015 | $931 |
2014 | $780 |
2013 | $839 |
2012 | $704 |
2011 | $593 |
2010 | $410 |
2009 | $321 |
Perrigo Quarterly EBITDA (Millions of US $) |
|
---|---|
2024-03-31 | $27 |
2023-12-31 | $71 |
2023-09-30 | $154 |
2023-06-30 | $151 |
2023-03-31 | $138 |
2022-12-31 | $130 |
2022-09-30 | $123 |
2022-06-30 | $73 |
2022-03-31 | $91 |
2021-12-31 | $119 |
2021-09-30 | $511 |
2021-06-30 | $-52 |
2021-03-31 | $141 |
2020-12-31 | $137 |
2020-09-30 | $175 |
2020-06-30 | $157 |
2020-03-31 | $179 |
2019-12-31 | $65 |
2019-09-30 | $156 |
2019-06-30 | $149 |
2019-03-31 | $197 |
2018-12-31 | $205 |
2018-09-30 | $-18 |
2018-06-30 | $201 |
2018-03-31 | $264 |
2017-12-31 | $266 |
2017-09-30 | $268 |
2017-06-30 | $255 |
2017-03-31 | $232 |
2016-12-31 | $-366 |
2016-09-30 | $-1,362 |
2016-06-30 | $289 |
2016-03-31 | $-129 |
2015-12-31 | $-476 |
2015-09-30 | $272 |
2015-06-30 | |
2015-03-31 | $247 |
2014-12-31 | $1,199 |
2014-09-30 | $137 |
2014-06-30 | |
2014-03-31 | $341 |
2013-12-31 | $1,042 |
2013-09-30 | $180 |
2013-06-30 | |
2013-03-31 | $291 |
2012-12-31 | $920 |
2012-09-30 | $157 |
2012-06-30 | |
2012-03-31 | $248 |
2011-12-31 | $871 |
2011-09-30 | $102 |
2011-06-30 | |
2011-03-31 | $199 |
2010-12-31 | $744 |
2010-09-30 | $112 |
2010-06-30 | |
2010-03-31 | $141 |
2009-12-31 | $600 |
2009-09-30 | $86 |
2009-06-30 | |
2009-03-31 | $123 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $3.467B | $4.656B |
Perrigo Co. plc, with a diversified revenue stream, sells infant formulas for the store brand market, generic extended topical prescription (Rx) products and specialty pharmaceutical drugs. It's focusing on self-care products as part of its transformation into a self-care company from a healthcare company. The company divested its Rx segment to Altaris Capital Partners. The company completed its transformation to a consumer self-care company by reconfiguring the portfolio through the divestiture of RX business. Currently, the company has 2 reporting segments. Consumer Self Care Americas (CSCA): The segment comprises the U.S., Mexico and Canada CHC business, including OTC, contract manufacturing, infant formula and animal health categories. Consumer Self Care International?(CSCI): The segment comprises the branded consumer healthcare (BCH) segment mainly in Europe and the company's consumer-focused businesses in the UK and Australia. This segment includes UK liquids licensed products business. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $182.053B | 23.84 |
Stryker (SYK) | United States | $129.729B | 31.07 |
Boston Scientific (BSX) | United States | $112.966B | 35.98 |
Medtronic (MDT) | Ireland | $101.722B | 15.23 |
EssilorLuxottica (ESLOY) | France | $99.494B | 0.00 |
Lonza Group Ag (LZAGY) | Switzerland | $40.384B | 0.00 |
Haleon (HLN) | United Kingdom | $38.493B | 28.10 |
ResMed (RMD) | United States | $28.144B | 26.42 |
Terumo (TRUMY) | Japan | $24.477B | 34.57 |
Koninklijke Philips (PHG) | Netherlands | $23.276B | 18.48 |
Zimmer Biomet Holdings (ZBH) | United States | $22.297B | 14.24 |
Baxter (BAX) | United States | $17.081B | 12.15 |
Insulet (PODD) | United States | $14.497B | 64.28 |
Smith & Nephew SNATS (SNN) | United Kingdom | $10.820B | 0.00 |
Demant (WILYY) | Denmark | $9.620B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $7.758B | 25.37 |
BellRing Brands (BRBR) | United States | $7.565B | 35.58 |
Lantheus Holdings (LNTH) | United States | $5.636B | 14.04 |
Haemonetics (HAE) | United States | $4.238B | 20.90 |
GN Store Nord (GNNDY) | Denmark | $4.222B | 23.71 |
Prestige Consumer Healthcare (PBH) | United States | $3.475B | 16.54 |
Neogen (NEOG) | United States | $3.457B | 33.25 |
ICU Medical (ICUI) | United States | $2.893B | 25.53 |
Envista Holdings (NVST) | United States | $2.832B | 11.69 |
TG Therapeutics (TGTX) | United States | $2.774B | 78.04 |
Green Thumb Industries (GTBIF) | United States | $2.724B | 53.33 |
Agios Pharmaceuticals (AGIO) | United States | $2.476B | 0.00 |
QuidelOrtho (QDEL) | United States | $2.246B | 12.47 |
LeMaitre Vascular (LMAT) | United States | $1.847B | 54.13 |
Maravai LifeSciences Holdings (MRVI) | United States | $1.784B | 0.00 |
Warby Parker (WRBY) | United States | $1.611B | 0.00 |
InMode (INMD) | Israel | $1.517B | 8.06 |
Verano Holdings (VRNOF) | United States | $1.455B | 0.00 |
AdaptHealth (AHCO) | United States | $1.313B | 9.76 |
AtriCure (ATRC) | United States | $1.108B | 0.00 |
Owens & Minor (OMI) | United States | $1.051B | 9.16 |
National Vision Holdings (EYE) | United States | $0.995B | 31.67 |
BioLife Solutions (BLFS) | United States | $0.944B | 0.00 |
Cresco Labs (CRLBF) | United States | $0.871B | 0.00 |
Phibro Animal Health (PAHC) | United States | $0.697B | 14.83 |
Evolus (EOLS) | United States | $0.684B | 0.00 |
PetIQ (PETQ) | United States | $0.659B | 21.31 |
Surmodics (SRDX) | United States | $0.598B | 37.47 |
VAREX IMAGING (VREX) | United States | $0.598B | 14.06 |
Canopy Growth (CGC) | Canada | $0.508B | 0.00 |
Quanterix (QTRX) | United States | $0.498B | 0.00 |
Valneva SE (VALN) | France | $0.497B | 0.00 |
ZimVie (ZIMV) | United States | $0.480B | 40.91 |
Biote (BTMD) | United States | $0.458B | 10.56 |
TerrAscend (TSNDF) | Canada | $0.426B | 0.00 |
Jin Medical (ZJYL) | China | $0.398B | 0.00 |
Cerus (CERS) | United States | $0.324B | 0.00 |
OraSure Technologies (OSUR) | United States | $0.312B | 10.05 |
Zynex (ZYXI) | United States | $0.287B | 39.26 |
Ayr Wellness (AYRWF) | United States | $0.266B | 0.00 |
MacroGenics (MGNX) | United States | $0.258B | 0.00 |
Aurora Cannabis (ACB) | Canada | $0.258B | 0.00 |
Viemed Healthcare (VMD) | United States | $0.251B | 24.89 |
Sanara MedTech (SMTI) | United States | $0.251B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.236B | 14.86 |
Omeros (OMER) | United States | $0.229B | 0.00 |
High Tide (HITI) | Canada | $0.182B | 0.00 |
Organigram Holdings (OGI) | Canada | $0.166B | 0.00 |
TriSalus Life Sciences (TLSI) | United States | $0.156B | 0.00 |
FitLife Brands (FTLF) | United States | $0.152B | 21.57 |
Capricor Therapeutics (CAPR) | United States | $0.148B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.132B | 0.00 |
Jushi Holdings (JUSHF) | United States | $0.130B | 0.00 |
Veru (VERU) | United States | $0.117B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.109B | 0.00 |
Brainsway (BWAY) | Israel | $0.100B | 0.00 |
Fonar (FONR) | United States | $0.100B | 10.11 |
InterCure (INCR) | Israel | $0.090B | 15.15 |
Cellectar Biosciences (CLRB) | United States | $0.084B | 0.00 |
Chimerix (CMRX) | United States | $0.080B | 0.00 |
Bright Green (BGXX) | United States | $0.073B | 0.00 |
MariMed (MRMD) | United States | $0.072B | 0.00 |
Eagle Pharmaceuticals (EGRX) | United States | $0.065B | 4.25 |
Allurion Technologies (ALUR) | United States | $0.062B | 0.00 |
Zevia PBC (ZVIA) | United States | $0.059B | 0.00 |
Safety Shot (SHOT) | United States | $0.055B | 0.00 |
Rockwell Medical (RMTI) | United States | $0.053B | 0.00 |
Modular Medical (MODD) | United States | $0.051B | 0.00 |
Apyx Medical (APYX) | United States | $0.049B | 0.00 |
United-Guardian (UG) | United States | $0.043B | 15.47 |
Cytosorbents (CTSO) | United States | $0.042B | 0.00 |
ImmuCell (ICCC) | United States | $0.034B | 0.00 |
Exagen (XGN) | United States | $0.032B | 0.00 |
Nephros (NEPH) | United States | $0.022B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.022B | 0.00 |
Agape ATP (ATPC) | $0.017B | 0.00 | |
Trinity Biotech (TRIB) | Ireland | $0.016B | 0.00 |
GUARDION HEALTH (GHSI) | United States | $0.013B | 0.00 |
Flora Growth (FLGC) | United States | $0.012B | 0.00 |
GlucoTrack (GCTK) | United States | $0.011B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
NeuroMetrix (NURO) | United States | $0.007B | 0.00 |
FSD PHARMA (HUGE) | Canada | $0.007B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
Leafly Holdings (LFLY) | United States | $0.006B | 0.00 |
Sharps Technology (STSS) | United States | $0.004B | 0.00 |
Senestech (SNES) | United States | $0.003B | 0.00 |
Lucy Scientific Discovery (LSDI) | Canada | $0.001B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
Smart For Life (SMFL) | United States | $0.000B | 0.00 |
Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
SNDL (SNDL) | Canada | $0.000B | 0.00 |